𝔖 Bobbio Scriptorium
✦   LIBER   ✦

E2F1 Expression is Related with the Poor Survival of Lymph Node-positive Breast Cancer Patients Treated with Fluorouracil, Doxorubicin and Cyclophosphamide

✍ Scribed by Sehwan Han; Kyeongmee Park; Byung-Noe Bae; Ki Hwan Kim; Hong-Joo Kim; Young-Duck Kim; Hong-Yong Kim

Book ID
111574949
Publisher
Springer US
Year
2003
Tongue
English
Weight
126 KB
Volume
82
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Doxorubicin and cyclophosphamide adjuvan
Doxorubicin and cyclophosphamide adjuvant chemotherapy is no more effective than cyclophosphamide, methotrexate, and 5-fluorouracil for premenopausal axillary lymph node positive breast cancer: There is no clear evidence that HER-2 status affects the relative effects of doxorubicin and cyclophosphamide vs cyclophosphamide, methotrexate and 5-fluorouracil in women with operable breast cancer
✍ Dino Amadori πŸ“‚ Article πŸ“… 2001 πŸ› Elsevier Science 🌐 English βš– 346 KB
High expression of 90K (Mac-2 BP) is ass
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies
✍ Nicola Tinari; Rossano Lattanzio; Patrizia Querzoli; Clara Natoli; Antonino Gras πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 234 KB

## Abstract 90K (Mac‐2 BP) expression was evaluated by immunohistochemistry in paraffin‐embedded tissue from a consecutive series of lymph‐node negative breast cancer patients who did not receive adjuvant systemic treatment. An independent series of patients served as validation set. The associatio